Target intelligence / Profile preview

RNA, U7 small nuclear 2 pseudogene (RNU7-2P)

Target
RNU7-2P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RNU7-2P is classified as a **pseudogene** of the U7 small nuclear RNA gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from duplication or retrotransposition events. The functional U7 small nuclear RNA is a component of the U7 snRNP complex involved in the 3'-end processing of replication-dependent histone pre-mRNA, a process critical for histone biosynthesis and, indirectly, DNA replication and cell proliferation[1][4][5]. However, as a pseudogene, RNU7-2P itself is not transcribed into a functional product and does not perform any known biological role or serve as a therapeutic target. RNU7-2P may be referenced in genomic studies and annotated in gene databases, but it lacks established function, disease association, or drug interactions[1][5]. **Key context:** - RNU7-2P is distinct from the functional U7 snRNA gene (RNU7-1 or RNU7) that is essential for histone mRNA processing[4]. - There are several U7 snRNA pseudogenes described in the human genome, but none are known to have a biological function[1][4][5]. - The functional U7 snRNA is minimally 57–70 nucleotides long, forms part of the U7 snRNP, and is critical for a specific pre-mRNA processing step unique to metazoan histone genes[4]. Pseudogenes such as RNU7-2P do not participate in this process. **Problem/limitation with this entry:** - **RNU7-2P is not a protein, enzyme, receptor, or any classical molecular therapeutic target;** it is a non-functional pseudogene for a small nuclear RNA. Therefore, it would not have expected molecular function, disease associations, nor drug interactions and should not be considered a therapeutic target[1][5]. - Databases may list variants of these pseudogenes, but most do not express stable or functional RNA products[4][5].

Other names
U7.2RNA, small nuclear U7.2 pseudogeneRNU7-2P

Beyond the preview

Go deeper on RNA, U7 small nuclear 2 pseudogene (RNU7-2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 small nuclear 2 pseudogene (RNU7-2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call